Wird geladen...
Bleeding in patients receiving non-vitamin K oral anticoagulants: clinical trial evidence
In optimizing anticoagulation therapy, it is essential to balance treatment efficacy with the major adverse effect of anticoagulant treatment, bleeding risk. This narrative review examines the efficacy and safety of the non-vitamin K antagonist oral anticoagulants (NOACs) dabigatran, rivaroxaban, ap...
Gespeichert in:
| Veröffentlicht in: | Ther Adv Cardiovasc Dis |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publications
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6266250/ https://ncbi.nlm.nih.gov/pubmed/30270775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753944718801554 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|